Rob de Bie

Rob de Mol van Raaijmakers & de Mol Advies

Rob de Bie is a neurologist and works at the Academic Medical Center in Amsterdam. In 2005-06, he did a Movement Disorders Fellowship with Prof Tony Lang in Toronto. His research focuses on the treatment of Parkinson's disease, including the current NSTAPS study.

Rob de Bie

Rob de Bie studied physiotherapy (graduated 1987, Deventer), human movement sciences (graduated in 1991, Maastricht University) and epidemiology (registered in 1992), obtained his PhD in 1998 and has been Associate Professor in Clinical Epidemiology at Maastricht University, the Netherlands from 1999 -2003.

Wereld Parkinson Dag 2016 Rob de Bie YouTube

Rob A de Bie currently works at the CAPHRI School for Public Health and Primary Care, Maastricht University. Rob does research in Musculoskeletal Disorders, etiology, prognosis and impact of.

Rob de Bie, hoogleraar Neurologische Bewegingsstoornissen Universiteit van Amsterdam

Rob de Bie Prof. PhD Full Professor, ANS - Neurodegeneration Full Professor, APH - Aging & Later Life Full Professor, Neurology PI 1997 2023 Specialization Neurology, Movement Disorders Focus of research Improving treatment of Movement Disorders.

Parkinson Geef aan onderzoek naar behandeling op maat ProPark (BS051) LUMC Campagne

Rob M A de Bie Academisch Medisch Centrum Universiteit van Amsterdam | AMC · Department of Neurology MD, PhD Connect with experts in your field Join ResearchGate to contact this researcher.

Anticiperen of acuut reageren de toekomst van intensive care Philips

Rob de Bie expand_more Education and qualifications (1) sort Sort Maastricht University - Location Randwyck: Maastricht, Limburg, NL 1987-09-01 to 1991-07-01 | MSc (Human Movement Sciences) Education Show more detail Source : Rob de Bie expand_more Works (12) sort Sort The Variability of Lumbar Sequential Motion Patterns: Observational Study

Karakteristieken voetbal regio Deventer / Zutphen Foto destentor.nl

Rob de Bie received financial support for a fellowship program from Medtronic, and has received research grants from ZonMw, Internationaal Parkinson Fonds, Prinses Beatrix Fonds, Michael J Fox Foundation, and Parkinson Vereniging. Günther Deuschl has received lecture fees from Orion, Lundbeck, Teva and Pfizer and has been serving as a.

Rob de Bie (RobAdeBie) Twitter

Rob de Bie focust zich vooral op het verbeteren van de behandeling van Parkinson. Hieronder valt de behandeling met diepe hersenstimulatie, die in het AMC ook bij mensen met andere bewegingsstoornissen wordt toegepast. De Bie heeft diverse grote klinische onderzoeken geïnitieerd en geleid die hebben bijgedragen aan de verbetering van de.

AL5GRJXTy3XnyKqU3GwkFM3wRCkzwPKwqkmlUIHs71JY=s900ckc0x00ffffffnorj

Rob A de Bie currently works at the CAPHRI School for Public Health and Primary Care, Maastricht University. Rob does research in Musculoskeletal Disorders, etiology, prognosis and impact of.

Rob de Bie's question about the construction at Volkel Aircraft WWII

Berid Rackwitz, Rob de Bie, Heribert Limm, Katharina von Garnier, Thomas Ewert, and Gerold Stucki. Clinical Rehabilitation 2006 20: 7, 553-567 Download Citation. If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below.

Wie is wie INfusie VErsus STimulatie

Cochrane Musculoskeletal group, Ottawa (p. Tugwell), Cochrane Back Group, Toronto (L. Bouter, C. Bombardier), Folkehelse, National institute for public health (K.

Rob de Leeuw Perfon

Professor of Movement Disorders Rob de Bie of Amsterdam Neuroscience works at Amsterdam UMC where he meets people with Parkinson's on a daily basis. De Bie is one of the main neurologists focusing on Parkinson's disease. "I'm driven by my daily experiences with people suffering from this disease", says de Bie.

Rob Snijders Senior Advisor Antilope De Bie printing LinkedIn

Until more effective methods of providing stable dopamine concentrations are developed, current evidence supports the use of levodopa as initial symptomatic treatment in most patients with Parkinson's disease, starting with low doses and titrating to therapeutic threshold.

Rob de Bie Hospital Patient Monitoring Manager BeNeLux Philips LinkedIn

DATA SYNTHESIS: We assessed bias using the Cochrane Risk-of-Bias tool (ROB 2.0) and therapeutic validity using the i-CONTENT tool. Standardized mean differences (Hedges' g) and 95% confidence intervals (CIs) were calculated for knee functioning.

two men standing next to each other in front of a train on the tracks and buildings

Rob de Bie Autoschade WStyle

Study design: A systematic review of randomized controlled trials. Objectives: To evaluate the effectiveness of segmental stabilizing exercises for acute, subacute and chronic low back pain with regard to pain, recurrence of pain, disability and return to work.